期刊文献+

Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats 被引量:4

Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats
在线阅读 下载PDF
导出
摘要 Objective:To observe the expression of matrix metalloproteinase-9(MMP-9)and mouse double minute 2 homolog(MDM2)in the oncogenesis of lung cancer in rats and to explore their clinical value.Methods:A total of 140 rats were selected,of which 20 were selected randomly as the control group;and the remaining 120 as the observation group.The observation group was injected with benzopyrene to establish diseases model such as tissue proliferation,abnormal proliferation and lung cancer.Delected the MMP-9 levels of lung tissue by enzyme-linked assay,detected the MDM2 levels of lung tissue by immunochemistry assay.Results:The MMP-9 and MDM2 expression of the lung cancer group and the abnormal proliferation group were significantly higher than that in the tissue proliferation group and the control group,the difference was significant(P<0.05).And the MDM2 expression of the tissue proliferation group was significantly higher than that in the control group,the difference was significant(P<0.05).There was no significant difference in the MMP-9 expression between the tissue proliferation group and the control group(P>0.05).The MDM2 and MMP-9 expression were increased in turn in the small cell carcinoma,squamous cell carcinoma and adenocarcinoma,the difference was statistically significant(P<0.05).The MMP-9 and MDM2 expressions of stageⅢand stageⅣlung cancer tissue in rats were significant higher than that during stageⅠand stageⅡ,the difference was significant(P<0.05).There was no significantly different in the MMP-9 and MDM2 expressions between stageⅢand stageⅣ(P>0.05),and there is no significant difference of the MMP-9and MDM2 expressions between stageⅠand stageⅡ(P>0.05).Conclusions:The expression of MMP-9 and MDM2 in lung tissue was associated with lung disease and lung cancer,both of them may be involved in the development and metastasis of lung cancer.Combined detection can be used as therapy and prognostic indicators for lung cancer. Objective:To observe the expression of matrix metalloproteinase-9(MMP-9)and mouse double minute 2 homolog(MDM2)in the oncogenesis of lung cancer in rats and to explore their clinical value.Methods:A total of 140 rats were selected,of which 20 were selected randomly as the control group;and the remaining 120 as the observation group.The observation group was injected with benzopyrene to establish diseases model such as tissue proliferation,abnormal proliferation and lung cancer.Delected the MMP-9 levels of lung tissue by enzyme-linked assay,detected the MDM2 levels of lung tissue by immunochemistry assay.Results:The MMP-9 and MDM2 expression of the lung cancer group and the abnormal proliferation group were significantly higher than that in the tissue proliferation group and the control group,the difference was significant(P&lt;0.05).And the MDM2 expression of the tissue proliferation group was significantly higher than that in the control group,the difference was significant(P&lt;0.05).There was no significant difference in the MMP-9 expression between the tissue proliferation group and the control group(P&gt;0.05).The MDM2 and MMP-9 expression were increased in turn in the small cell carcinoma,squamous cell carcinoma and adenocarcinoma,the difference was statistically significant(P&lt;0.05).The MMP-9 and MDM2 expressions of stageⅢand stageⅣlung cancer tissue in rats were significant higher than that during stageⅠand stageⅡ,the difference was significant(P&lt;0.05).There was no significantly different in the MMP-9 and MDM2 expressions between stageⅢand stageⅣ(P&gt;0.05),and there is no significant difference of the MMP-9and MDM2 expressions between stageⅠand stageⅡ(P&gt;0.05).Conclusions:The expression of MMP-9 and MDM2 in lung tissue was associated with lung disease and lung cancer,both of them may be involved in the development and metastasis of lung cancer.Combined detection can be used as therapy and prognostic indicators for lung cancer.
机构地区 Department of Oncology
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2014年第7期585-588,共4页 亚太热带医药杂志(英文版)
关键词 LUNG cancer ADENOCARCINOMA MDM2 MMP-9 Lung cancer Adenocarcinoma MDM2 MMP-9
  • 相关文献

参考文献9

二级参考文献68

  • 1李喜霞,郎旭宇,乔从进,崔慧林,郭睿.原癌基因pokemon mRNA及其蛋白在非小细胞肺癌中的表达和意义[J].中国组织化学与细胞化学杂志,2009,18(1):89-93. 被引量:5
  • 2赵敏,陆江阳,吕艺.高迁移率族蛋白B1的生物学效应及在几种疾病发病中的作用[J].军事医学科学院院刊,2005,29(1):91-95. 被引量:12
  • 3MOLl, U M, PETRENKO O. The MDM2-p53 interaction[J]. Molecular Cancer Research, 2003, 1 (14) : 1001-1008.
  • 4KAWAGUCHI K, ODA Y, SAKAMOTO A, et al. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years[J]. Modern Pathology, 2002, 15(8): 878-888.
  • 5DWORAKOWSKA D, JASSEM E, JASSEM J, et al. MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)[J]. Lung Cancer, 2004, 43(3): 285-295.
  • 6MA H, PEDERSON T. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway [J]. Molecular Biology of the Cell, 2007, 18(7): 2630-2635.
  • 7MENG L, LIN T, TSAI R Y. Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival[J]. Journal of Cell Science, 2008, 121 ( Pt24 ) : 4037-4046.
  • 8TANG J M, HE Q Y, GUO R X, et al. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis[J]. Lung Cancer, 2006, 51(2): 181-191.
  • 9TSAI R Y, MCKAY R D. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells[J]. Genes & Development, 2002, 16(23 ) : 2991-3003.
  • 10OLINER J D, PIETENPOL J A, THIAGALINGAM S, et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53[J]. Nature, 1993, 362(6423): 857-860.

共引文献18

同被引文献28

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部